Public Health – Page 13

Ecolabels and the Impact on Healthfulness and Carbon Footprint of Restaurant Meal Choices: A Randomized Clinical Trial

By MedXY 09/11/2025

This clinical trial found that ecolabels on restaurant menus can reduce the carbon footprint of meals without compromising nutritional quality, highlighting ecolabels as a promising low-cost strategy for sustainable dining.

Family Medicine & Nutrition Public Health Specialties

Does Using Your Phone While Charging Increase Radiation? Unpacking the Science and Safety

By MedXY 09/11/2025

Explore how phone charging affects electromagnetic radiation levels, what this means for health, and practical tips to reduce exposure while keeping your device safe.

Public Health Specialties Urology

Unveiling the Hidden Risks of 5G Radiation: Impacts on Male Fertility

By MedXY 09/11/2025

Recent animal studies suggest daily 5G phone radiation exposure may significantly impair sperm quality, raising concerns over modern lifestyle and reproductive health.

Pediatrics Public Health Specialties

Technology, Ethics, and Equity: Navigating the Three Core Challenges in Large-Scale Genomic Newborn Screening for Universal Health Benefits

By MedXY 09/11/2025

Genomic newborn screening shows promise for early detection of a wider range of diseases but raises significant technological, ethical, and equity challenges before becoming a universally accessible public health tool.

news Public Health Specialties

Hospital Addiction Consult Services: A Promising Step to Reduce Emergency Visits Among Patients with Opioid Use Disorder

By MedXY 09/11/2025

A hospital-based addiction consult program lowered emergency department visits in opioid use disorder patients but did not reduce hospitalizations or mortality, highlighting the need for comprehensive care beyond hospital walls.

Clinical Updates news Public Health Specialties

Impact of Physician-Personalized Videos and Infographics on Influenza Vaccination Rates: Findings from a Randomized Clinical Trial

By MedXY 09/11/2025

This trial assessed if videos and infographics from primary care physicians improve flu vaccination rates; overall effects were minimal, but notable improvements occurred in children.

Psychiatry Public Health Specialties

Impact of Graphic Health Warnings on Little Cigar and Cigarillo Use: Evidence from a Randomized Clinical Trial

By MedXY 09/11/2025

A randomized trial demonstrates that graphic health warnings on little cigars and cigarillos significantly increase quitting intentions and related behaviors compared to FDA text-only warnings or no warnings, highlighting the need for enhanced packaging policies.

Public Health Specialties

Impact of a $40 Monthly Healthy Food Benefit on Food Security and Fruit and Vegetable Intake in Lower-Income Populations

By MedXY 09/11/2025

A cohort study found that a $40 monthly healthy food benefit program significantly improved food security and increased the frequency of fruit and vegetable consumption among lower-income urban adults, highlighting its potential to reduce nutrition-related health disparities.

Emergency Medicine Infectious Diseases Public Health Specialties

Optimizing Hepatitis C Screening in Emergency Departments: Insights from the DETECT Hep C Randomized Clinical Trial

By MedXY 09/11/2025

The DETECT Hep C trial demonstrates nontargeted HCV screening in emergency departments identifies more new infections than risk-based approaches, though linkage to care remains suboptimal, underscoring the need for innovative treatment models.

Clinical Updates news Public Health Specialties

The Dawn of the “No-Clinical-Trial” Era for Biosimilars: FDA’s Historic Ustekinumab Approval Shift

By MedXY 09/06/2025

The US FDA's unprecedented exemption of clinical efficacy studies for a ustekinumab biosimilar marks a transformative regulatory milestone, reshaping biosimilar development, market dynamics, and patient access worldwide.

Clinical Updates Internal Medicine news Public Health Respiratory Specialties

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults: Insights from the DANFLU-2 Randomized Clinical Trial

By MedXY 09/06/2025

The DANFLU-2 trial demonstrates that high-dose influenza vaccine reduces cardiovascular and cardiorespiratory hospitalizations compared to standard-dose in adults ≥65 years, with similar benefits across subgroups including heart failure and atherosclerotic cardiovascular disease.

Cardiology Public Health Specialties

Enhanced Protection in Heart Failure: High-Dose Influenza Vaccine Outperforms Standard Dose in the DANFLU-2 Trial

By MedXY 09/06/2025

The DANFLU-2 trial reveals that high-dose influenza vaccine significantly reduces hospitalization for influenza and cardiovascular events in older adults, including those with heart failure, compared to the standard-dose vaccine.

Cardiology Clinical Updates Public Health Specialties

PANDA II Trial Confirms Influenza Vaccination as Essential Intervention for Acute Heart Failure Patients

By MedXY 09/03/2025

The PANDA II study demonstrates that influenza vaccination significantly reduces mortality and rehospitalization in acute heart failure patients, supporting its inclusion as a standard component of heart failure management worldwide.

Infectious Diseases Public Health Specialties

Azelastine Nasal Spray Significantly Reduces SARS-CoV-2 Infection Risk: Results from a Phase 2 Randomized Clinical Trial

By MedXY 09/02/2025

This phase 2 trial demonstrates that azelastine nasal spray reduces SARS-CoV-2 infections and symptomatic respiratory illnesses in a healthy, vaccinated adult population, suggesting its potential as a safe, scalable prophylactic measure against COVID-19.

Clinical Updates Infectious Diseases news Public Health Specialties

Evaluating RSV Vaccine Effectiveness Against Hospitalization in US Adults Aged 60 and Older Over Two Seasons

By MedXY 09/01/2025

A large multicenter study demonstrates that a single dose of RSV vaccine reduces hospitalization risk by 58% among adults aged 60+, with lower effectiveness in immunocompromised and cardiovascular patients.

Cardiology news Public Health Respiratory Specialties

Bivalent RSV Prefusion F Protein Vaccine: A Potential Strategy to Reduce Cardiovascular Hospitalizations in Older Adults

By MedXY 09/01/2025

The DAN-RSV trial demonstrates that RSV vaccination significantly lowers all-cause cardiorespiratory hospitalizations among older adults, suggesting vaccines may reduce infection-triggered cardiovascular complications and benefit chronic disease management.

Family Medicine & Nutrition Medical News Public Health Specialties

Invisible Invaders: How Microplastics Penetrate Our Bodies and What You Can Do About It

By MedXY 09/01/2025

Microplastics, tiny plastic particles under 5mm, have silently infiltrated our bodies through drinking water, air, and food. They accumulate in organs, accelerate cell aging, and increase inflammation. Learn hidden sources and practical tips to reduce exposure.

Family Medicine & Nutrition news Public Health Specialties

Invisible Intruders: Microplastics Found in Every Human Placenta Sample Tested

By MedXY 08/31/2025

Recent research shows microplastics present in 100% of 62 human placentas analyzed, raising concerns about prenatal exposure and future health implications.

Family Medicine & Nutrition Medical News news Public Health Specialties

Microwaving Plastic Containers: A Hidden Source of Billions of Microplastic Particles in Your Food

By MedXY 08/31/2025

Recent research reveals that microwaving plastic food containers can release billions of micro- and nanoplastic particles into food, posing potential health risks, especially to infants and young children. Understanding this silent contamination is vital for safer food practices.

Public Health Specialties

FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults

By MedXY 08/31/2025

The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna designed to target the LP.8.1 sublineage, expanding vaccination to adults over 65 and individuals with high-risk conditions, enhancing immune defense against evolving variants.